Acamar Partners Acquisition Corp. (ACAM) to Combine with CarLotz in $827Mn Deal

carlotz-4x6

Acamar Partners Acquisition Corp. (ACAM) to Combine with CarLotz in $827Mn Deal

Oct 22, 2020 INTEL by Kristi Marvin

Acamar Partners Acquisition Corp. (ACAM), a publicly-traded special purpose acquisition company, and CarLotz, Inc., one of the largest privately-held used vehicle retail disruptors with the industry’s only consignment-to-retail sales platform, announced today they executed a definitive business combination agreement that would make CarLotz a public company. At closing, anticipated in the fourth quarter of 2020,
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Alert-2

Tenzing Acquisition Corp. (TZAC) Adds a Backstop

Tenzing Acquisition Corp. (NASDAQ:TZAC) announced in an 8-K filing this morning that it has entered into a backstop agreement ahead of its shareholder vote to approve its combination with Reviva Pharmaceutics. According to the agreement, Reviva and other investors to purchase a total 417,518 shares through either private or open-market transactions by October 23. For
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
4dpharma

Longevity Acquisition Corporation (LOAC) to Combine with 4D pharma PLC

Longevity Acquisition Corporation (NASDAQ:LOAC) announced this morning it has signed a definitive merger agreement with 4D pharma PLC (AIM:DDDD) that would list the company in the US. 4D is developing medications that use human gut bacteria to potentially treat a range of diseases including certain types of cancer, neurodegenerative conditions and autoimmune diseases. The deal
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Pivotal-xl-fleet-4x6
Teaser

Alberton Acquisition Corp. (ALAC) Drops a Teaser

Oct 22, 2020 INTEL by Kristi Marvin
Alberton Acquisition Corp. (ALAC), put out an 8-K this morning announcing some changes to it’s board, but also included a teaser ahead of it’s forthcoming extension vote on Monday, October 26th. Notably, Mr. John W. Allen resigned from his positions as an independent director and the chairman of the compensation committee and Mr. Harry Edelson
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
ipo
YAC_Logo2
nuvation-bio

Panacea Acquisition Corp. (PANA) to Combine with Nuvation Bio in $1.3Bn Deal

Biotech firm Nuvation Bio announced this morning that it had entered into a definitive business combination agreement with Panacea Acquisition Corp. (NYSE:PANA) for an enterprise value of about $1.3 billion. New York-based Nuvation Bio is developing six novel treatments for a variety of cancer types. The combined company is to be remain listed on the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
Supernova-logo
IPO
ipo
IPO-Pricing
SPAC risk
IPO-Pricing
monocle-aersale
IPO-Pricing